Scarica l'app Stockscreener
10.89
2.72%
-0.325
4 D Molecular Therapeutics Inc Borsa (FDMT) Ultime notizie
How does 4D Molecular Therapeutics Inc (FDMT) change from a tortoise to a hare? - setenews.com
Can 4D Molecular Therapeutics Inc. stock weather global recessionMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Applying big data sentiment scoring on 4D Molecular Therapeutics Inc.Options Play & Free Expert Verified Stock Movement Alerts - newser.com
Backtesting results for 4D Molecular Therapeutics Inc. trading strategiesTrade Analysis Summary & Safe Swing Trade Setups - newser.com
Why 4D Molecular Therapeutics Inc. stock remains on watchlistsDollar Strength & Weekly Top Performers Watchlists - newser.com
Is 4D Molecular Therapeutics Inc. stock ready for a breakoutMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
4D Molecular Therapeutics Partners with Otsuka for APAC Market - MSN
4D Molecular Therapeutics (FDMT) Stock: Soars on $85M Otsuka Deal to Expand 4D-150 Across APAC - parameter.io
4D Molecular Shares Rise Premarket on Partnership With Otsuka - MarketScreener
4D Molecular (FDMT) Forms Key Partnership with Otsuka Pharmaceutical - GuruFocus
FDMT licenses 4D-150 in APAC to Otsuka with $85M upfront - Stock Titan
4D Molecular Therapeutics, Inc. Enters into Collaboration and License Agreement with Otsuka Pharmaceutical Co., Ltd - MarketScreener
4D Molecular Therapeutics Announces Strategic Partnership with Otsuka Pharmaceutical Co. Ltd. to Develop and Commercialize 4D-150 for Treatment of Wet AMD and DME in APAC Region Including Japan - MarketScreener
4D Molecular Therapeutics Announces Strategic Partnership with Otsuka for Development of 4D-150 in Asia-Pacific Markets - Quiver Quantitative
4DMT (NASDAQ: FDMT) licenses 4D-150 to Otsuka in APAC; $85M upfront, $336M milestones - Stock Titan
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific - Yahoo Finance
How institutional ownership impacts 4D Molecular Therapeutics Inc. stockTreasury Yields & Daily Chart Pattern Signal Reports - newser.com
4D Molecular Therapeutics, Inc. (FDMT) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
4D Molecular Therapeutics, Inc. (FDMT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
4D Molecular Therapeutics Advances Gene Therapy Trial for Fabry Disease - MSN
4D Molecular Therapeutics Advances Phase 3 Trial for Vision Loss Treatment - MSN
4D Molecular Therapeutics Advances in Macular Degeneration Treatment: A Phase 3 Study Update - MSN
4D Molecular Therapeutics Appoints New Financial Officer - MSN
Will 4D Molecular Therapeutics Inc. stock see insider buying2025 Stock Rankings & Proven Capital Preservation Methods - fcp.pa.gov.br
What is the fair value of 4D Molecular Therapeutics Inc. stock now2025 Biggest Moves & AI Driven Stock Reports - newser.com
4D Molecular Therapeutics Executive Sells Shares - TradingView
FDMT insider trade: options at $6.49, sale at $12 on 10/24/2025 - Stock Titan
4D Molecular Therapeutics Advances Gene Therapy for Wet AMD - TipRanks
4D Molecular Therapeutics Advances Gene Therapy Trial for Cystic Fibrosis - TipRanks
4D Molecular Therapeutics Secures Up to $11M More from CF Foundation to Accelerate 4D-710 Development - Insider Monkey
4D Molecular Therapeutics’ (FDMT) “Outperform” Rating Reiterated at Royal Bank Of Canada - Defense World
Can 4D Molecular Therapeutics Inc. stock resist sector downturnsWeekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
RBC Capital Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT) - The Globe and Mail
RBC Capital Reiterates 4D Molecular Therapeutics (FDMT) Outperform Recommendation - Nasdaq
What recovery options are there for 4D Molecular Therapeutics Inc.Risk Management & Expert Approved Momentum Trade Ideas - newser.com
How to build a dashboard for 4D Molecular Therapeutics Inc. stockOptions Play & Free Expert Verified Stock Movement Alerts - newser.com
Bizily, 4D Molecular Therapeutics CLO, sells $16,627 in FDMT stock - Investing.com India
Bizily, 4D Molecular Therapeutics CLO, sells $16,627 in FDMT stock By Investing.com - Investing.com Nigeria
4D Molecular Therapeutics insider trade under 10b5-1 plan - Stock Titan
Wall Street Analysts See a 208.52% Upside in 4D Molecular Therapeutics (FDMT): Can the Stock Really Move This High? - MSN
Does 4D Molecular Therapeutics Inc. stock trade at a discount to peers2025 Pullback Review & Reliable Momentum Entry Alerts - nchmf.gov.vn
Will 4D Molecular Therapeutics Inc. stock benefit from AI adoption2025 Top Gainers & Real-Time Chart Pattern Alerts - nchmf.gov.vn
Leerink Partnrs Issues Optimistic Estimate for FDMT Earnings - Defense World
How 4D Molecular Therapeutics Inc. stock responds to policy changesTrade Volume Report & Free Growth Oriented Trading Recommendations - Trung tâm Dự báo KTTV quốc gia
4DMT Announces New Employment Inducement Grants - GlobeNewswire
1.24%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):